Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NPM1‐mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions
Brunangelo Falini
American Journal of Hematology (2023) Vol. 98, Iss. 9, pp. 1452-1464
Open Access | Times Cited: 19

Showing 19 citing articles:

The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
Menin Inhibitors: New Targeted Therapies for Specific Genetic Subtypes of Difficult-to-Treat Acute Leukemias
Pasquale Niscola, Valentina Gianfelici, Marco Giovannini, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 142-142
Open Access
LST1 expression correlates with immune infiltration and predicts poor prognosis in acute myeloid leukemia
Haitao Xu, Dangui Chen, Jia Lu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Tumor-Derived Extracellular Vesicles: Hijacking T cell Function through Exhaustion
Renhua Guo, Ping Wang
Pathology - Research and Practice (2025), pp. 155948-155948
Closed Access
Intensive Induction Chemotherapy versus Hypomethylating Agents in Combination with Venetoclax in NPM1-mutant AML
Jan Philipp Bewersdorf, Shai Shimony, Rory M. Shallis, et al.
Blood Advances (2024) Vol. 8, Iss. 18, pp. 4845-4855
Open Access | Times Cited: 2
Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience
Paul Jäger, Christina Rautenberg, Jennifer Kaivers, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations
Frode Selheim, Elise Aasebø, Håkon Reikvam, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5080-5080
Open Access | Times Cited: 1
PROteolysis‐Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives
André T. S. Vicente, Jorge A. R. Salvador
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 1
Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia
Jun Ren, Junpeng Huang, Zailin Yang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Infrequent Presentations of Chronic NPM1-Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature
Sandra Castaño‐Díez, Francesca Guijarro, Mònica López‐Guerra, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 705-705
Open Access
LST1 Expression Correlates with Immune Infiltration and Predicts Poor Prognosis in Acute Myeloid Leukemia
Haitao Xu, Dangui Chen, Long Zhong, et al.
Research Square (Research Square) (2024)
Open Access
Early Prediction and Streamline of Nucleophosmin Mutation Status in Acute Myeloid Leukemia Using Cup-Like Nuclear Morphology
Ljubomir Jaković, Vesna Djordjević, Nada Kraguljac Kurtović, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1443-1443
Open Access
The prognostic significance of genetics in acute myeloid leukemia under venetoclax-based treatment
Shan Zheng, Yuxin Tong, Linlin Yang, et al.
Annals of Hematology (2024)
Closed Access
HOXA9 Regulome and Pharmacological Interventions in Leukemia
Sajesan Aryal, Rui Lu
Advances in experimental medicine and biology (2024), pp. 405-430
Closed Access
Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?
Sandra Castaño‐Díez, José Ramón Álamo Moreno, Mònica López‐Guerra, et al.
The Oncologist (2024)
Open Access
Recent progress in AML with recurrent genetic abnormalities
Yuichi Ishikawa
International Journal of Hematology (2024)
Closed Access
Survival impact of hypoxia-inducible factor-1 alpha (HIF-1α) in Nucleophosmin1 mutated acute myeloid leukemia
Chantiya Chanswangphuwana, Narittee Sukswai, Nichthida Tangnuntachai, et al.
Annals of Hematology (2024)
Closed Access
DNMT/G9a Complex Inhibition Uncovers Epigenetic Vulnerabilities and Induces IFN-Response in Acute Myeloid Leukemia
Angelique Schönefeld, Costanza Zanetti, E. Schmitt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Targeting AML Growth: Vitamins' Influence on FLT3, NPM1, and RUNX1 Interactions
Tunnisha Dasgupta, Rounak Chatterjee, Moumita Mondal, et al.
Research Square (Research Square) (2023)
Open Access
The acidic stretch and the C-terminal nuclear export signal motif of NPM1 mutant: are they druggable in AML?
Brunangelo Falini, Bjørn Tore Gjertsen, Vibeke Andresen
Leukemia (2023) Vol. 37, Iss. 11, pp. 2173-2175
Closed Access
Page 1

Scroll to top